EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Medication use and treatment patterns in children and adolescents with chronic tic disorders: an EMTICS study

Orit Peled, Daphna Shoham, Tamar Steinberg, Alan Apter, Dana Feldman-Sadeh, Miri Carmel, Idan Barak, Zsanett Tarnok, Peter Nagy, Abraham Weizman, Pieter J Hoekstra, Andrea Dietrich und 2 weitere

European Child & Adolescent Psychiatry · 2026

DOI: 10.1007/s00787-026-03120-5 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Child & Adolescent Psychiatry, 2026. Verfasst von Orit Peled und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Schneider Children's Medical Center of Israel, Petah Tikvah, Petah Tikvah, Israel. Hauptthemen laut MEDLINE: Tic Disorders, Attention Deficit Disorder with Hyperactivity, Obsessive-Compulsive Disorder, Antipsychotic Agents. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tel Aviv University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment of tic disorders in children and adolescents poses significant challenges, especially when comorbid conditions such as obsessive-compulsive disorder (OCD) and attention-deficit/hyperactivity disorder (ADHD) are present. Pharmacological treatments are often guided by clinical judgment, prescriber preferences, and medication availability. This study describes pharmacological treatment use in a large cohort of children and adolescents with chronic tic disorders (CTDs). We analyzed baseline data from the European Multicenter Tics in Children Study (EMTICS) to examine associations between medication use, tic severity, and psychiatric comorbidities, using parent-reported questionnaires and clinical interviews to assess tics, obsessive-compulsive disorder (OCD), attention-deficit/hyperactivity disorder (ADHD), oppositional defiant disorder (ODD), and children’s self-rated premonitory urges. Among 709 children aged 3–16 years with CTDs, 230 (32%) received any pharmacological treatment, 22% received antipsychotics and 10% received ADHD medications, with limited use of alpha-2 agonists (3%). Medication use was more common among individuals with comorbid ADHD (54%) than those with CTD only (23%) or comorbid OCD only (26%). Those on tic-suppressing medications had significantly greater severity of tics, tic-related impairment, and comorbid ADHD, ODD, and obsessive symptom severity compared to those with non-tic-suppressing medications. There was no relationship with the severity of compulsions or premonitory urges. While largely consistent with published guidelines, these findings indicate limited utilization of recommended agents, such as alpha-2 agonists, alongside higher reported symptom severity among those receiving tic-suppressing medications. Further studies should explore the integration of pharmacological, behavioral, and psychoeducational approaches tailored to comorbidity profiles and symptom severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tic DisordersAttention Deficit Disorder with HyperactivityObsessive-Compulsive DisorderAntipsychotic AgentsAdrenergic alpha-2 Receptor AgonistsHumansAdolescentChildMaleFemaleComorbidityOppositional Defiant DisorderChild, PreschoolSeverity of Illness IndexEuropeChronic Disease

Stichwörter der Autor:innen

Attention deficit disorder (ADHD)MedicationsPsychopharmacologyTic disordersTourette syndrome

Substanzen

Antipsychotic AgentsAdrenergic alpha-2 Receptor Agonists

Autor:innen und Institutionen

  • Department of Pharmacy, Schneider Children's Medical Center of Israel, Petah Tikvah, Petah Tikvah, Israel.
  • Adelson School of Medicine, Ariel University, Ariel, Israel.
  • Department of Child and Adolescent Psychiatry, Schneider Children's Medical Center of Israel, Petah Tikvah, 4920235, Israel.
  • Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Institute of Child Neurology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
  • Research Unit, Geha Mental Health Center, and Laboratory of Molecular and Biological Psychiatry, Felsenstein Medical Research Center, Petah Tikvah, Israel.

Förderung

  • Tel Aviv University

Zitieren

APA

Peled, O., Shoham, D., Steinberg, T., Apter, A., Feldman-Sadeh, D., Carmel, M., Barak, I., Tarnok, Z., Nagy, P., Weizman, A., Hoekstra, P. J., Dietrich, A., EMTICS collaborative group, & Benaroya-Milshtein, N. (2026). Medication use and treatment patterns in children and adolescents with chronic tic disorders: an EMTICS study. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-026-03120-5

Vancouver

Peled O, Shoham D, Steinberg T, Apter A, Feldman-Sadeh D, Carmel M, et al. Medication use and treatment patterns in children and adolescents with chronic tic disorders: an EMTICS study. European Child & Adolescent Psychiatry. 2026. doi:10.1007/s00787-026-03120-5

BibTeX
@article{Peled2026,
  author = {Peled, Orit and Shoham, Daphna and Steinberg, Tamar and Apter, Alan and Feldman-Sadeh, Dana and Carmel, Miri and Barak, Idan and Tarnok, Zsanett and Nagy, Peter and Weizman, Abraham and Hoekstra, Pieter J and Dietrich, Andrea and EMTICS collaborative group, EMTICS collaborative group and Benaroya-Milshtein, Noa},
  title = {Medication use and treatment patterns in children and adolescents with chronic tic disorders: an EMTICS study},
  journal = {European Child & Adolescent Psychiatry},
  year = {2026},
  doi = {10.1007/s00787-026-03120-5}
}
Kostenlos starten →